Bokus

Centre for Medicines Research Workshop – serie

Visar alla böcker i serien Centre for Medicines Research Workshop. Handla med fri frakt och snabb leverans.

9 produkter

  1. C. Lumley, S.R. Walker - Improving the Regulatory Review Process, Inbunden. Tillgänglighet: Lägg i varukorg

    Improving the Regulatory Review Process

    Industry and Regulatory Initiatives

    Av C. Lumley, S.R. Walker

    Inbunden, 1996

    1692 kr

    Lägg i varukorg

    Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process …

  2. McAuslane, J. A. Neil McAuslane, J.A.Neil McAuslane, Stuart R. Walker - Improving the Regulatory Review Process, Inbunden. Tillgänglighet: Lägg i varukorg

    Improving the Regulatory Review Process

    Assessing Performance and Setting Targets

    Av McAuslane, J. A. Neil McAuslane m. fl.

    Inbunden, 1998

    905 kr

    Lägg i varukorg

    At a time when it is becoming usual for medicines to be developed for a global market and pharmaceutical companies are endeavouring to expedite the drug development process, Regulatory authorities are concentrating on improving their efficiency and effectiveness. Therefore, it is not surprising …

  3. Susan A. Griffiths, C. Lumley - Safety Evaluation of Biotechnologically-derived Pharmaceuticals, Inbunden. Tillgänglighet: Lägg i varukorg

    Safety Evaluation of Biotechnologically-derived Pharmaceuticals

    Facilitating a Scientific Approach

    Av Susan A. Griffiths, C. Lumley

    Inbunden, 1998

    1130 kr

    Lägg i varukorg

    Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate …

  4. Stuart Walker, J. A. Neil McAuslane, Stuart R. Walker, Cyndy E. Lumley, Neil McAuslane - Relevance of Ethnic Factors in the Clinical Evaluation of Medicines, Inbunden. Tillgänglighet: Lägg i varukorg

    Relevance of Ethnic Factors in the Clinical Evaluation of Medicines

    Medicines

    Av Stuart Walker, J. A. Neil McAuslane m. fl.

    Inbunden, 1994

    905 kr

    Lägg i varukorg

    There is currently limited acceptance of foreign clinical data by regulatory authorities, although the reasons for repeating studies are poorly defined. There are some proven genetic differences in drug metabolism and elimination which occur with varying frequencies in different populations. In …

  5. S.R. Walker, Anthony D. Dayan - Long-Term Animal Studies, Inbunden. Tillgänglighet: Lägg i varukorg

    Long-Term Animal Studies

    Their Predictive Value for Man

    Av S.R. Walker, Anthony D. Dayan

    Inbunden, 1986

    2252 kr

    Lägg i varukorg

  6. S.R. Walker, C. Lumley, N. McAuslane - Relevance of Ethnic Factors in the Clinical Evaluation of Medicines, Häftad. Tillgänglighet: Lägg i varukorg

    Relevance of Ethnic Factors in the Clinical Evaluation of Medicines

    Proceedings of a Workshop held at The Medical Society of London, UK, 7th and 8th July, 1993

    Av S.R. Walker, C. Lumley m. fl.

    Häftad, 2012

    569 kr

    Lägg i varukorg

    For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible and for many companies these will include …

  7. N. McAuslane, S.R. Walker - Improving the Regulatory Review Process: Assessing Performance and Setting Targets, Häftad. Tillgänglighet: Lägg i varukorg

    Improving the Regulatory Review Process: Assessing Performance and Setting Targets

    Av N. McAuslane, S.R. Walker

    Häftad, 2012

    504 kr

    Lägg i varukorg

    At a time when it is becoming usual for medicines to be developed for a global market and pharmaceutical companies are endeavouring to expedite the drug development process, Regulatory Authorities are concentrating on improving their efficiency and effectiveness. Therefore, it is not surprising …

  8. Susan A. Griffiths, C. Lumley - Safety Evaluation of Biotechnologically-derived Pharmaceuticals, Häftad. Tillgänglighet: Lägg i varukorg

    Safety Evaluation of Biotechnologically-derived Pharmaceuticals

    Facilitating a Scientific Approach

    Av Susan A. Griffiths, C. Lumley

    Häftad, 2012

    1002 kr

    Lägg i varukorg

    Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate …

  9. C. Lumley, S.R. Walker - Improving the Regulatory Review Process, Häftad. Tillgänglighet: Lägg i varukorg

    Improving the Regulatory Review Process

    Industry and Regulatory Initiatives

    Av C. Lumley, S.R. Walker

    Häftad, 2011

    1500 kr

    Lägg i varukorg

    Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process …